Astera Labs, Inc. (NASDAQ:ALAB) Receives Average Rating of "Moderate Buy" from Analysts

Key Points

• Analysts maintain a constructive outlook: Astera Labs has a “Moderate Buy” consensus rating from 21 analysts, with an average 12-month price target of $348.33.
• Strong operating results exceeded expectations: Quarterly EPS came in at $0.80 versus the $0.69 consensus, while revenue reached $392.4 million, up 104.5% year over year. Management guided for third-quarter EPS of $1.16 to $1.21.
• Valuation and insider selling remain risks: The stock has declined recently despite its growth outlook, trades at a high earnings multiple, and insiders have sold substantial shares, including more than $209 million over the past 90 days.

Shares of Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) have earned an average rating of "Moderate Buy" from the twenty-one analysts that are covering the company, Marketbeat.com reports. Eight research analysts have rated the stock with a hold recommendation, twelve have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target among analysts that have covered the stock in the last year is $348.3333.

A number of research firms have weighed in on ALAB. Roth Capital reissued a "buy" rating and issued a $450.00 target price on shares of Astera Labs in a research note on Wednesday, August 5th. TD Cowen dropped their price target on Astera Labs from $425.00 to $375.00 and set a "hold" rating for the company in a research report on Wednesday, August 5th. Susquehanna increased their price target on Astera Labs from $230.00 to $275.00 and gave the company a "neutral" rating in a report on Friday, July 31st. Needham & Company LLC lifted their price objective on Astera Labs from $260.00 to $425.00 and gave the stock a "buy" rating in a research report on Wednesday, August 5th. Finally, Northland Securities raised Astera Labs from a "market perform" rating to an "outperform" rating and set a $350.00 price objective on the stock in a research note on Monday, August 17th.

Insider Buying and Selling at Astera Labs

In other news, General Counsel Philip Mazzara sold 6,801 shares of the business's stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the transaction, the general counsel owned 96,542 shares of the company's stock, valued at approximately $32,872,551. The trade was a 6.58% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 8,994 shares of the company's stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the completion of the sale, the director directly owned 3,970 shares of the company's stock, valued at $1,237,965.10. This represents a 69.38% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 592,244 shares of company stock worth $209,729,973. Corporate insiders own 10.40% of the company's stock.

Institutional Trading of Astera Labs

Several hedge funds have recently made changes to their positions in the company. Parkside Financial Bank & Trust increased its holdings in shares of Astera Labs by 74.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 96 shares of the company's stock worth $46,000 after buying an additional 41 shares during the last quarter. Corient Private Wealth LP lifted its holdings in Astera Labs by 69.9% in the second quarter. Corient Private Wealth LP now owns 21,689 shares of the company's stock valued at $10,476,000 after acquiring an additional 8,922 shares during the last quarter. Brown Financial Advisors purchased a new position in Astera Labs in the second quarter worth approximately $217,000. HighTower Advisors LLC grew its position in Astera Labs by 5.0% in the second quarter. HighTower Advisors LLC now owns 10,129 shares of the company's stock worth $4,893,000 after acquiring an additional 478 shares during the period. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Astera Labs during the second quarter worth $5,206,000. Hedge funds and other institutional investors own 60.47% of the company's stock.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Demand for Astera Labs’ Scorpio, Aries and Taurus connectivity platforms is supporting expectations for strong third-quarter growth and strengthening the company’s position in AI data-center infrastructure. ALAB Stock Down 24% in a Month: Should Investors Buy the Dip or Wait?
• Positive Sentiment: The company’s latest quarterly results exceeded expectations, with earnings per share of $0.80 versus the $0.69 consensus estimate and revenue of $392.4 million versus $360.85 million. Revenue rose 104.5% year over year, while management issued third-quarter EPS guidance of $1.16 to $1.21.
• Positive Sentiment: Analyst sentiment remains generally constructive: Astera Labs has a “Moderate Buy” consensus rating and an average price target of $348.33, above recent trading levels. Northland upgraded the shares to outperform with a $350 target, while Morgan Stanley maintained an overweight rating with a $335 target.
• Neutral Sentiment: Despite the favorable growth outlook, ALAB has declined 13.9% since its latest earnings report and 24% over the past month, reflecting elevated valuation expectations and uncertainty about the pace of future growth. The stock’s high beta and elevated earnings multiple may contribute to volatility. Why Is Astera Labs Down Since Its Earnings Report?
• Negative Sentiment: Director Manuel Alba sold 183,000 shares for approximately $51.3 million, reducing his holdings by 41.9%. Director Stefan Dyckerhoff separately sold 12,499 shares worth about $3.4 million. The transactions were made under pre-arranged Rule 10b5-1 plans, which reduces their value as a discretionary bearish signal, but the sales may still weigh on investor sentiment and add near-term supply. SEC Insider Trading Filing

Astera Labs Price Performance

Astera Labs stock opened at $310.40 on Monday. Astera Labs has a 52-week low of $97.89 and a 52-week high of $499.48. The firm has a market capitalization of $53.85 billion, a price-to-earnings ratio of 153.66 and a beta of 3.77. The company has a fifty day simple moving average of $330.74 and a 200-day simple moving average of $255.24.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company's revenue for the quarter was up 104.5% on a year-over-year basis. During the same period last year, the firm posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts anticipate that Astera Labs will post 2.7 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source